Showing results (181-190 of 571) with videos related to

Sort By:
Pageof 58
Genes|September 27, 2025
Cardiac Phenotypes in Fabry Disease: Genetic Variability and Clinical Severity Staging Correlation in a Reference Center CohortDenise Cristiana Faro, Serena Di Salvo, Margherita Stefania Rodolico, et al.
Expert Review of Clinical Pharmacology|May 17, 2021
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendationsMattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 16, 2024
Switching from cangrelor to oral P2Y12 inhibitors: a focused review on drug-drug interactionsGiovanni Occhipinti, Luis Ortega-Paz, Francesco Franchi, et al.
Thrombosis and Haemostasis|October 21, 2011
Platelet function profiles in the elderly: results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivityPiera Capranzano, Claudia Tamburino, Davide Capodanno, et al.
Atherosclerosis|December 15, 2025
Association between C-reactive protein and adverse events in secondary cardiovascular prevention: A systematic review and meta-analysis of prognostic factor studiesRaffaele Piccolo, Angelo Laino, Antonio Pio Vitale, et al.
American Heart Journal|August 27, 2023
A review of polypills for the prevention of atherosclerotic cardiovascular diseaseFederica Agnello, Simone Finocchiaro, Claudio Laudani, et al.
Mayo Clinic Proceedings|February 5, 2025
Relevance of High Bleeding Risk and Postdischarge Bleeding in Patients Undergoing Percutaneous Coronary InterventionBrenden S Ingraham, Marco Valgimigli, Dominick J Angiolillo, et al.
Circulation. Cardiovascular Interventions|July 28, 2025
Advances in the Detection and Management of Vulnerable Coronary PlaquesMarco Spagnolo, Daniele Giacoppo, Claudio Laudani, et al.
Journal of Interventional Cardiology|February 12, 2011
Does occlusion duration influence procedural and clinical outcome of patients who underwent percutaneous coronary intervention for chronic total occlusion?Salvatore D Tomasello, Luca Costanzo, Maria B Campisano, et al.
Lancet (London, England)|April 18, 2021
Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisMattia Galli, Stefano Benenati, Davide Capodanno, et al.
Pageof 58